- Home
- VLRS vs SAGE Comparison
VLRS vs SAGE Comparison
Compare VLRS & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLRS
- SAGE
- Stock Information
- Founded
- VLRS 2005
- SAGE 2010
- Country
- VLRS Mexico
- SAGE United States
- Employees
- VLRS N/A
- SAGE N/A
- Industry
- VLRS Air Freight/Delivery Services
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- VLRS Consumer Discretionary
- SAGE Health Care
- Exchange
- VLRS Nasdaq
- SAGE Nasdaq
- Market Cap
- VLRS 546.3M
- SAGE 571.7M
- IPO Year
- VLRS N/A
- SAGE 2014
- Fundamental
- Price
- VLRS $4.82
- SAGE $9.08
- Analyst Decision
- VLRS Strong Buy
- SAGE Hold
- Analyst Count
- VLRS 6
- SAGE 18
- Target Price
- VLRS $8.35
- SAGE $10.06
- AVG Volume (30 Days)
- VLRS 769.0K
- SAGE 2.8M
- Earning Date
- VLRS 07-21-2025
- SAGE 07-30-2025
- Dividend Yield
- VLRS N/A
- SAGE N/A
- EPS Growth
- VLRS N/A
- SAGE N/A
- EPS
- VLRS 0.04
- SAGE N/A
- Revenue
- VLRS $3,052,207,000.00
- SAGE $47,404,000.00
- Revenue This Year
- VLRS $2.04
- SAGE $102.21
- Revenue Next Year
- VLRS $12.38
- SAGE $43.01
- P/E Ratio
- VLRS $13.33
- SAGE N/A
- Revenue Growth
- VLRS N/A
- SAGE N/A
- 52 Week Low
- VLRS $3.49
- SAGE $4.62
- 52 Week High
- VLRS $9.00
- SAGE $13.47
- Technical
- Relative Strength Index (RSI)
- VLRS 58.86
- SAGE 71.54
- Support Level
- VLRS $4.31
- SAGE $9.04
- Resistance Level
- VLRS $4.46
- SAGE $9.30
- Average True Range (ATR)
- VLRS 0.19
- SAGE 0.15
- MACD
- VLRS 0.04
- SAGE 0.05
- Stochastic Oscillator
- VLRS 87.58
- SAGE 91.35
About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.
Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.